ZP1848 Publications



ZP1848 Publications

Skarbaliene, J., Petersen, Y.M., Christjansen, K., Ebbehoej, K., Pedersen, H.D., and Thorkildsen, C.:
ZP1848, a novel GLP-2 agonist, provides a wide window of therapeutic efficacy in the experimental Crohn’s disease model
Abstract for Digestive Disease Week , May 7-10, 2011, Chicago, IL 
Poster no. Su1953, page A-779

Knudsen, C.B. and Jensen, A.L.
Simultaneous Quantitative Determination of ZP1848 and Two Metabolites in Human Plasma Using Immunoaffinity-Precipitation LC/MS/MS
“2010 AAPS National Biotechnology Conference” in San Francisco, CA, USA, May 16-19 2010
Poster

Petersen, Y.M., Skarbaliene, J., Christjansen, K., Björkenberg, B., Ebbenhoej, K. Larsen, K. Duelund, H., and Thorkildsen, C.:
Effective attenuation of small intestinal inflammation using a novel small intestinal mucosal enhancer: ZP1848.
Poster (P1012) at United European Gastroenterology Week 2009, UEGW/WCOG, 21-25 November 2009, London.
Poster
Gut, 2009, 58 (Suppl II), A308

Petersen, Y.M., Björkenberg, B., Hyttel, J., Knudsen, C.B., and Thorkildsen, C.:
Plasma Citrulline is a marker of ZP1848-induced small intestinal growth in wistar rats.
Oral presentation (OP381) at United European Gastroenterology Week 2009, UEGW/WCOG, 21-25 November 2009, London
Gut, 2009, 58 (Suppl II), A80-A81
Presentation

Petersen, Y.M. Björkenberg,B., Christjansen, K.,  Stahlhut, M., Pedersen, H.D.,  and  Thorkildsen, C.:
Is the murine dextran sodium sulfate-induced colitis model valid for predicting drug efficacy in IBD
American Gastroenterological Association- Digestive Diseases Week 2009.Chicago, USA, May 30 to June 4, 2009
Abstract
Presentation

Petersen, Y.M., Clausen, T.S., Kjølbye, A., Ørskov, A., Petersen, J.S. Larsen, B.D., Holst, J.J. and Poulsen, S.S.:
ZP1848, a new high efficacy glucagon-like peptide 2 mimetic, prevents indomethacin-induced inflammation in the small intestine in rats.
Annual meeting - Pharmacology of Membrane Proteins: from molecule to clinic. Joint meeting between The German Pharmacological Society and The Danish Society of Pharmacology and Toxicology, 21-22 June 2007, Copenhagen, Denmark
Poster Abstract No. 20, Meeting Programme p 41
Poster

Petersen. Y.M., Clausen, T.S., Kjølbye, A., Ørskov, C., Petersen, J.S.,  Larsen, B.D., Holst, J.J. and Poulsen, S.S.:
ZP1848, a new high efficacy glucagon-like peptide 2 mimetic, prevents indomethacin-induced inflammation in the small intestine in rats.
Poster abstract for 14th United European Gastroenterology Week (UEGW 2006), 21-25 October 2006, Berlin, Germany. Poster MON-G-247
Gut, 2006, 55, Supplement No. V, A130

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.



Related links